Acquired Resistance to EGFR Inhibitors Is Associated with a Manifestation of Stem Cell-like Properties in Cancer CellsSHIEN, Kazuhiko; TOYOOKA, Shinichi; TSUKUDA, Kazunori et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 10, pp 3051-3061, issn 0008-5472, 11 p.Article

EGFR Antagonists in Cancer TreatmentCIARDIELLO, Fortunato; TORTORA, Giampaolo.The New England journal of medicine. 2008, Vol 358, Num 11, pp 1160-1174, issn 0028-4793, 15 p.Article

Bioimpact of EGFR antagonists on the pilosebaceous folliclesPIERARD, Gerald E; PIERARD-FRANCHIMONT, Claudine; HUMBERT, Philippe et al.EJD. European journal of dermatology. 2012, Vol 22, Num 1, pp 54-57, issn 1167-1122, 4 p.Article

Syndrome mains-pieds : nouvel effet secondaire de l'erlotinib = Hand-foot syndrome : A new side effect of erlotinibROUXEL, A.-M; ROGUEDAS, A.-M; DESCOURT, R et al.Annales de dermatologie et de vénéréologie. 2008, Vol 135, Num 11, pp 762-764, issn 0151-9638, 3 p.Article

Sym004: A Novel Synergistic Anti-Epidermal Growth Factor Receptor Antibody Mixture with Superior Anticancer EfficacyPEDERSEN, Mikkel Wandahl; JACOBSEN, Helle Jane; KOEFOED, Klaus et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 2, pp 588-597, issn 0008-5472, 10 p.Article

EGFR Inhibitor-Associated Acneiform Folliculitis : Assessment and ManagementDUVIC, Madeleine.American journal of clinical dermatology. 2008, Vol 9, Num 5, pp 285-294, issn 1175-0561, 10 p.Article

Effect of in vivo administered hexachlorobenzene on epidermal growth factor receptor levels, protein tyrosine kinase activity, and phosphotyrosine content in rat liverRANDI, Andrea S; SANCOVICH, Horacio A; FERRAMOLA DE SANCOVICH, Ana M et al.Biochemical pharmacology. 2003, Vol 65, Num 9, pp 1495-1506, issn 0006-2952, 12 p.Article

Emerging role of epidermal growth factor receptor inhibition in therapy for advanced malignancy: Focus on NSCLCLANGER, Corey J.International journal of radiation oncology, biology, physics. 2004, Vol 58, Num 3, pp 991-1002, issn 0360-3016, 12 p.Conference Paper

EGFR signaling attenuates Groucho-dependent repression to antagonize Notch transcriptional outputHASSON, Peleg; EGOZ, Nirit; WINKLER, Clint et al.Nature genetics. 2005, Vol 37, Num 1, pp 101-105, issn 1061-4036, 5 p.Article

Vascular Endothelial Growth Factor Receptor-1 Contributes to Resistance to Anti : Epidermal Growth Factor Receptor Drugs in Human Cancer CellsBIANCO, Roberto; ROSA, Roberta; ALBINI, Adriana et al.Clinical cancer research (Print). 2008, Vol 14, Num 16, pp 5069-5080, issn 1078-0432, 12 p.Article

Blockade of epidermal growth factor receptor (EGFR) activityJIMENO, Antonio; HIDALGO, Manuel.Critical reviews in oncology/hematology. 2005, Vol 53, Num 3, pp 179-192, issn 1040-8428, 14 p.Article

Targeting Stat3 Abrogates EGFR Inhibitor Resistance in CancerSEN, Malabika; JOYCE, Sonali; PANAHANDEH, Mary et al.Clinical cancer research (Print). 2012, Vol 18, Num 18, pp 4986-4996, issn 1078-0432, 11 p.Article

Effets cutanés des nouvelles molécules utilisées en cancérologie = New drugs in oncology and skin toxicityMATEUS, C; ROBERT, C.La Revue de médecine interne (Paris). 2009, Vol 30, Num 5, pp 401-410, issn 0248-8663, 10 p.Article

The TGFβ―miR200―MIG6 Pathway Orchestrates the EMT-Associated Kinase Switch That Induces Resistance to EGFR InhibitorsIZUMCHENKO, Evgeny; XIAOFEI CHANG; SIDRANSKY, David et al.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 14, pp 3995-4005, issn 0008-5472, 11 p.Article

VECTIBIX^® (panitumumab, Amgen) Anticorps anti-EGFRRANCIERE, Fanny; DEBRIX, Isabelle; SELLE, Frédéric et al.Onko +. 2011, Vol 3, Num 23, pp 149-151, issn 2101-9495, 3 p.Article

Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumoursMONTEIRO, L. S; BENTO, M. J; PALMEIRA, C et al.Journal of oral pathology & medicine. 2009, Vol 38, Num 6, pp 508-513, issn 0904-2512, 6 p.Article

Synthesis and biological evaluation of crown ether fused quinazoline analogues as potent EGFR inhibitorsSHAOJING HU; GUOJIAN XIE; YINXIANG WANG et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 19, pp 6301-6305, issn 0960-894X, 5 p.Article

Topical therapy with nadifloxacin cream and prednicarbate cream improves acneiform eruptions caused by the EGFR-inhibitor cetuximab ― A report of 29 patientsKATZER, Kerstin; TIETZE, Julia; KLEIN, Elisabeth et al.EJD. European journal of dermatology. 2010, Vol 20, Num 1, pp 82-84, issn 1167-1122, 3 p.Article

Design and synthesis of 4,6-substituted-(diaphenylamino)quinazolines as potent EGFR inhibitors with antitumor activityLI, Huan-Qiu; LI, Dong-Dong; XIANG LU et al.Bioorganic & medicinal chemistry. 2012, Vol 20, Num 1, pp 317-323, issn 0968-0896, 7 p.Article

Incapacité motrice et fasciite radiologique sous erlotinib = Functional impairment and radiologic fasciitis under erlotinib therapyOSDOIT, S; WIERZBICKA, E; GUILLET, G et al.Annales de dermatologie et de vénéréologie. 2011, Vol 138, Num 6-7, pp 494-498, issn 0151-9638, 5 p.Article

Discovery of novel selective inhibitors for EGFR-T790M/L858RFANG BAI; HONGYAN LIU; HONGLIN LI et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 3, pp 1365-1370, issn 0960-894X, 6 p.Article

MECHANISMS OF RESISTANCE TO EGFR INHIBITORS IN HEAD AND NECK CANCERCOOPER, Jonathan B; EDDY WYSSAM COHEN, Ezra.Head & neck. 2009, Vol 31, Num 8, pp 1086-1094, issn 1043-3074, 9 p.Article

Carcinomas unresponsive to either cisplatinum or Anti-EGFR therapy can be growth inhibited by combination therapy of both agentsKNECHT, R; PETERS, S; ADUNKA, O et al.Anticancer research. 2003, Vol 23, Num 3B, pp 2577-2583, issn 0250-7005, 7 p.Article

Epidermal growth factor receptor is a predictor of tumor response in locally advanced rectal cancer patients treated with preoperative radiotherapyGIRALT, Jordi; ERASO, Aranzazu; ARMENGOL, Manel et al.International journal of radiation oncology, biology, physics. 2002, Vol 54, Num 5, pp 1460-1465, issn 0360-3016, 6 p.Article

Synthesis and biological evaluation of quinazoline and quinoline bearing 2,2,6,6-tetramethylpiperidine-N-oxyl as potential epidermal growth factor receptor(EGFR) tyrosine kinase inhibitors and EPR bio-probe agentsSIYUAN LI; CHUNYING GUO; XIANQIANG SUN et al.European journal of medicinal chemistry. 2012, Vol 49, pp 271-278, issn 0223-5234, 8 p.Article